Articles tagged with Immune System
Scientists at Lund University have developed a barcode system to track the development of immune cells, revealing that stem cells undergo different stages of maturation. This discovery has significant implications for understanding leukemia and autoimmune diseases.
After major trauma, debris from damaged cell powerhouses triggers an immune response in the kidneys, leading to permanent damage or destruction. Researchers aim to prevent this by understanding how formyl peptide receptors activate the immune system.
A study by Duke University researchers found that manipulating dopamine signaling can control inflammation in the gut, providing a proof of principle for using drugs originally designed to target the nervous system to treat immune system disorders such as rheumatoid arthritis and autoimmune disease.
Researchers suggest that duration of T-cell interactions with dendritic cells may be key to matching immune response to infection severity. Understanding this process could lead to advancements in vaccine development and the study of autoimmune diseases.
Researchers at the Gladstone Institutes have developed a new method to consistently activate mesenchymal stromal cells to produce anti-inflammatory proteins, enhancing their immune-suppressing effects. This breakthrough could lead to improved treatments for inflammatory bowel disease and organ transplant rejection.
A new study published in Nature Medicine shows that a natural immune system protein called IL-2 can help restore balance to the overactive immune system of lupus patients. The drug, originally used to boost the immune system for cancer treatment, has been found safe and effective in clinical trials.
Researchers found that blocking specific cell signaling pathways may reduce the risk of preterm labor caused by inflammation or stop it altogether. The study also identified key molecules in the Notch signaling pathway, paving the way for therapies to control preterm labor in humans.
Researchers at Duke University Medical Center have discovered key immune differences that can help in the development of an effective HIV vaccine. The study found that HIV-infected individuals with broadly neutralizing antibodies had similar immune alterations as those with autoimmune disease.
Scientists have discovered the molecular structure of a key Zika virus protein, shedding light on its role in viral reproduction and immune system interaction. The study provides new insights into the NS1 protein's functions and potential targets for vaccine development.
Researchers identified specific parasite proteins that trigger an antitumor immune response in mice with ovarian tumors. The discovery could lead to the development of new therapies using Toxoplasma gondii, a parasite that has been shown to cure mice of solid tumors.
A new study by University of Maryland School Medicine researchers has identified key aspects of the Mucorales fungi that may lead to treatment development. The fungus invades weakened immune systems, causing sometimes-deadly mucormycosis infections.
Researchers modeled co-evolution of antibodies and viruses to understand conditions for broadly neutralizing antibodies to emerge. They found that presenting the immune system with a large diversity of viral antigens may prompt the emergence of such potent antibodies, which could defeat broad swaths of viral strains.
Scientists at Saint Louis University are studying an investigational vaccine for yellow fever, a potentially deadly disease spread by the same mosquito that transmits Zika virus. The vaccine aims to provide protection to vulnerable groups who are at increased risk of complications if they receive the current vaccine.
Researchers at Ohio State University have identified a potential gene-based treatment for Candida albicans, which can cause deadly hospital-acquired bloodstream infections. By targeting the CBLB gene, the immune system can be boosted to effectively combat the infection.
A new Yale study found that warmer body temperatures impaired key immune system proteins in human airway cells, but did not completely disable the immune response. Researchers also identified two additional mechanisms that contribute to defense against the cold virus at core body temperature.
Researchers at Aarhus University discovered how simvastatin reduces inflammation in chronic diseases like rheumatoid arthritis and multiple sclerosis. The study found that simvastatin acts as a 'plug' in proteins retaining immune cells, reducing inflammation and improving symptoms.
Joanna Kreitinger, a University of Montana graduate student, has been awarded a prestigious immunology fellowship to study immune cell development and contribute to understanding lung diseases. Under Professor David Shepherd's leadership, her research aims to develop new drugs to treat diseases of the immune system.
The study reveals that Group B streptococcus (GBS) uses the enzyme hyaluronidase to evade the immune system during pregnancy, leading to neonatal morbidity and mortality. Blocking this enzyme could lead to eradication of GBS and new treatments for other ascending infections.
A Weizmann Institute study found that viral infection during pregnancy disrupts the fetal immune system, leading to abnormal brain development and increased risk of neurodevelopmental disorders. The study suggests a possible explanation for how maternal infections raise the risk of autism and schizophrenia in offspring.
Researchers found MAIT cells can bypass specific receptors to react to cytokine combinations, previously only known for fighting bacteria. The discovery suggests MAIT cells could be involved in defending against or reducing the effects of viruses.
Researchers at Vanderbilt University Medical Center are recruiting volunteers for a clinical trial aimed at decoding the human immunome. The study, part of the Human Vaccines Project, will generate data on the genetic underpinnings of the immune system to guide next-generation vaccine development.
A high-fibre diet shaped by fibre and short-chain fatty acids boosts dendritic cells, which control allergic responses, reducing allergy symptoms. The study suggests that a lack of fibre may promote food allergies in infants due to low levels of vitamin A.
A BU researcher has received a $2.95 million grant to investigate the relationship between immune cells and type 2 diabetes, with the goal of developing new treatments for both conditions.
A study by Stanford University researchers has identified CD47, a protein highly expressed on the surface of small-cell lung cancer cells, as a potential therapeutic target. Blocking this protein with immunotherapies may stimulate the immune system to destroy cancer cells, offering new hope for treating this deadly disease.
Researchers at Stanford University School of Medicine have identified Rac1 as a potential target for treating psoriasis. The small protein is involved in wound repair and has been linked to environmental triggers of the disease, as well as genetic predisposition. Blocking Rac1 activation may offer a new way to treat psoriasis without s...
GAM is a free web service that identifies links between changes in metabolism and genes, enabling better understanding of complex biological processes. The program can analyze entire maps of metabolic pathways in cells, revealing mechanisms of tumor growth and shedding light on autoimmune pathologies.
New evidence suggests that even with a healthy diet, defects in immune system function from birth can contribute to malnourished states throughout life. Researchers propose targeting immune pathways as a potential approach to reducing poor health and mortality caused by under- and overnutrition.
A review by Queen Mary University of London suggests that malnutrition can cause immune system dysfunction, making children more susceptible to common infections. This altered immune system may be passed down through generations, contributing to a range of physiological problems.
A microscopic parasite causes blindness, birth defects, and severe health consequences in hundreds of millions worldwide. Dr. Zhicheng Dou aims to develop a 100% cure for the disease by designing drugs that starve the parasite from host cells.
Researchers at Umeá University have developed a new method to directly follow viral infections in living organisms, making infected cells produce fluorescent proteins. This method enables the manipulation of cells to produce specific proteins, allowing for detailed study of immune system responses.
Researchers found that differences in immune cell parameters correlate with an individual's immune response to the flu vaccine. People who show a better antibody response after vaccination have higher levels of specific proteins on dendritic cells and more B cells, indicating improved immunity against flu.
A molecular pathway in brain helps halt spread of intestinal bacteria into bloodstream, strengthening gut barrier to prevent immune system activation. Researchers discover genetic switch Crtc plays key role in maintaining this barrier.
Researchers have identified a snitch that reveals cancer cells to the immune system by producing interferon, activating macrophages and T cells to kill cancer cells. MUS81 enzyme plays a crucial role in this process, triggering an immune response in cancer cells.
Researchers at Duke University Medical Center have developed an antibody that selectively attacks cancer cells while sparing healthy ones. The antibody works by targeting a specific protein on cancer cells, disabling their defense mechanism and triggering an immune response.
A study of 295,420 infants in Bavaria found increased T1D risk associated with respiratory tract infections between 2-9 months and 3-5.9 months of age. Early exposure to viral infections may impair immune system response, suggesting a crucial first half-year of life for autoimmunity development.
A global study found that gut microbiomes of infants in Finland and Estonia are dominated by Bacteroides species, while Russian Karelian infants have an overrepresentation of Bifidobacterium. This difference may contribute to the spike in immune disorders seen in western societies.
A Boston College research team, led by biologist Tim van Opijnen, is developing new technologies to predict drug resistance in certain bacteria and identify effective treatments. The five-year study will use cutting-edge genomics research tools and techniques to understand how bacteria interact with the immune system.
A new study found that coral reefs use platelet activating factor (PAF) to trigger inflammation, a key process in bringing in protective immune cells. This molecule has been part of human immune systems for over 550 million years, suggesting a common evolutionary origin.
Researchers discovered hidden mechanisms of the immune system in two disease areas, COPD and systemic lupus erythematosus. The findings showed that ILC2s can change into inflammatory cells in response to stimuli, suggesting a potential way to treat COPD exacerbations.
Researchers at the University of Minnesota have created a new model to study the human immune system, using 'dirty mice' that mimic the exposure to microbes found in humans. This new model has shown to improve the accuracy of potential therapeutics and vaccines.
Researchers at IBS Center for Vascular Health have created a new targeted agent to mitigate sepsis progression by strengthening and protecting blood vessels. This approach, utilizing the Tie2 receptor and anti-angiopoietin-2 antibody ABTAA, has shown enhanced survival rates in severe sepsis models up to 70%.
A new study funded by the National Institute of Allergy and Infectious Diseases proposes that co-housing laboratory mice with mice from pet stores could produce
A new study reveals that laboratory mice infected with common human viruses develop an immune system similar to newborn humans, but unlike adult humans. This finding suggests that the lack of infection may be a reason why research mice differ from humans.
Research found that TNF-alpha induces immune surveillance cells called M cells, which promote the body's ability to regulate and suppress inflammatory responses. This discovery could lead to more targeted drug therapies for treating IBD and other autoimmune diseases.
A biodegradable nanoparticle acts like a Trojan horse to convince the immune system not to attack an allergen, shutting down allergic reactions and preventing asthma attacks. The technology also shows promise in treating food allergies.
Researchers have identified a key role for a recently discovered immune cell in age-related inflammation and disease. The discovery sheds light on the mechanisms underlying these conditions and offers promising avenues for treatment.
Researchers have discovered how compounds produced by the body's immune system help to dampen inflammation and prevent damage to healthy tissues. These compounds, called alpha defensins, may act on cells of the immune system to prevent excessive inflammation.
Researchers from Johns Hopkins Medicine found that immune cells associated with allergies can promote healing of mouse muscle wounds when paired with biomaterial scaffolds. The discovery suggests a pivotal role for type 2 helper T cells in regulating the regenerative process, which may lead to novel strategies for tissue regeneration.
Researchers found that some frogs in Arizona are rapidly adapting to the fungal pathogen Batrachochrytrium dendrobatridis, which causes chytridiomycosis. The study identified a specific genetic variant, allele Q, that confers immunity to the disease, and showed that these variants were being rapidly inherited and evolving.
A new immune-suppressing drug regimen has led to the longest survival yet for a cross-species heart transplant, involving pig hearts in baboons. The study's results could lead to increased use of xenotransplantation and potentially help severe organ shortage among human patients.
Researchers at McMaster University have identified a critical step in the immune system's recognition of DNA viruses, which could lead to vaccinations for herpes, the common cold, and even cancer. The discovery involves an interaction between proteins S6K1 and STING that triggers antiviral responses.
A new study suggests that a combined vaccine therapy using live Salmonella is safe and effective in preventing diabetes in mice. The vaccine works by rebalancing the immune system and preventing the attack on insulin-producing cells. Researchers believe this targeted immunotherapy has great potential for treating type 1 diabetes.
Researchers found that certain gut bacteria can shield the brain from stroke by directing immune cells to protect it. Modifying the microbiotic makeup of the gut may become a novel method to prevent stroke, particularly for high-risk patients.
Researchers propose using 'sticky molecules' like IgA to target good bacteria in the gut, preventing pathogenic species from taking hold. This approach has the potential to reduce inflammation and prevent diseases such as Crohn's and ulcerative colitis.
Researchers have discovered an HIV-fighting immunogen called eOD-GT8 that shows extraordinary binding affinity for naïve human B cells, outperforming previous candidates by a factor of 2100. Approximately 96% of humans harbor B cells sensitive to this immunogen, suggesting its potential as a viable HIV vaccine strategy.
Researchers found that butyrate production is reduced in the intestinal tract of experimental mice after bone marrow transplantation, leading to an increased risk of graft vs. host disease. Increasing butyrate levels can mitigate this condition by bolstering the gut lining's resistance to the donor immune system.
A new study in mice suggests that a mother's microbiome shapes her offspring's immune system. The research found that maternal antibodies facilitate the transmission and retention of microbial molecules from a mother to her offspring.
A study led by the University of Edinburgh's MRC Centre for Inflammation Research discovered a mechanism to keep bacteria in the gut. The researchers found that PGE2 activates innate lymphoid cells, which help maintain the gut barrier and prevent body-wide inflammation.
Scientists have developed novel insulin mimetopes that can induce regulatory T cells to produce tolerance against insulin, halting the development of type 1 diabetes in young mice. In a humanized mouse model, the new vaccine efficiently stimulates regulatory T cells, which can impede the immune system's attack on insulin-producing cells.
A study by Pavel Kovarik and his team at the University of Vienna reveals that type I interferons play a crucial role in regulating IL-1β levels, preventing excessive inflammation and balance in the immune system.